Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Consumer advocacy organization Public Citizen has filed (PDF) a Freedom of Information Act (FOIA) lawsuit against the ...

Pfizer has agreed to acquire weight-loss drugmaker Metsera in a transaction that could exceed $10 billion. Under the terms of the cash deal, Pfizer will pay $65.60 a share upfront, along with a ...

While Pfizer gained approval for its drug tafamidis to treat a rare and fatal heart disease, whether insurers and employers will cover the drug’s list price — $225,000 — remains uncertain, according ...

The drug giant's experimental lung cancer drug, crizotinib, will be reviewed on a priority basis by U.S. regulators for treatment of patients with a certain form of the disease. The FDA will ...

(Reuters) -Pfizer filed a second lawsuit on Monday accusing Danish drugmaker Novo Nordisk of structuring its $9 billion bid for Metsera to stall the entry of the biotech firm's treatments into the ...

Pfizer Inc. Chief Executive Albert Bourla had long searched for an obesity drug to make up for dwindling sales of the pharma company’s aging blockbusters. Late Friday, after a dramatic bidding war, he ...

COVID-19 tweets from November 2020 have come back to haunt Pfizer once again. Fourteen months after an old tweet caused Pfizer new problems, pandemic-era social media posts linked to the drugmaker ...